Related Experiment Video
Updated: Aug 23, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
Nan Wang1, Debin Lan, Wengen Chen
1Department of Medicine, Division of Molecular Medicine, Columbia University, New York, NY 10032, USA. nw30@columbia.edu
Insights
Two newly identified transporters, ABCG1 and ABCG4, facilitate cellular cholesterol removal to high-density lipoprotein (HDL). This discovery offers a potential mechanism explaining how HDL levels influence atherosclerotic cardiovascular disease risk.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Science
Background:
- The link between high-density lipoprotein (HDL) levels and atherosclerotic cardiovascular disease (ASCVD) is inverse but mechanistically unclear.
- ATP-binding cassette transporter A1 (ABCA1) facilitates cholesterol efflux to lipid-poor apolipoproteins, not to mature HDL particles.
Purpose of the Study:
- To investigate the function of ABCG1 and ABCG4 in cellular cholesterol efflux to HDL.
- To elucidate the role of these transporters in the context of ASCVD risk.
Main Methods:
- Utilized transfected 293 cells to assess cholesterol efflux mediated by ABCG1 and ABCG4.
- Investigated the effect of liver X receptor (LXR) activation and RNA interference on ABCG1 expression and cholesterol efflux in macrophages.
Main Results:
- ABCG1 and ABCG4 were shown to mediate cholesterol efflux to both HDL-3 and HDL-2 subclasses.
- LXR activator treatment upregulated ABCG1 expression and increased cholesterol efflux to HDL in macrophages.
- RNA interference knockdown of ABCG1 reduced cholesterol efflux to HDL in activated macrophages.
Conclusions:
- ABCG1 and ABCG4 actively promote cellular cholesterol efflux to HDL particles.
- ABCG1, highly expressed in macrophages, likely mediates cholesterol removal from foam cells to HDL, potentially explaining the inverse relationship between HDL and ASCVD risk.
Abstract:
The mechanisms responsible for the inverse relationship between plasma high-density lipoprotein (HDL) levels and atherosclerotic cardiovascular disease are poorly understood. The ATP-binding cassette transporter A1 (ABCA1) mediates efflux of cellular cholesterol to lipid-poor apolipoproteins but not to HDL particles that constitute the bulk of plasma HDL. We show that two ABC transporters of unknown function, ABCG1 and ABCG4, mediate isotopic and net mass efflux of cellular cholesterol to HDL. In transfected 293 cells, ABCG1 and ABCG4 stimulate cholesterol efflux to both smaller (HDL-3) and larger (HDL-2) subclasses but not to lipid-poor apoA-I. Treatment of macrophages with an liver X receptor activator results in up-regulation of ABCG1 and increases cholesterol efflux to HDL. RNA interference reduced the expression of ABCG1 in liver X receptor-activated macrophages and caused a parallel decrease in cholesterol efflux to HDL. These studies indicate that ABCG1 and ABCG4 promote cholesterol efflux from cells to HDL. ABCG1 is highly expressed in macrophages and probably mediates cholesterol efflux from macrophage foam cells to the major HDL fractions, providing a mechanism to explain the relationship between HDL levels and atherosclerosis risk.
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Clearance: Role of Transporters
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
ABC Transporters: Exporter

